Autor: |
Claessens AKM; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands., Busschbach JJV; Department of Psychiatry, Section of Medical Psychology and Psychotherapy, Erasmus Medical Centre, Rotterdam, The Netherlands., Ramaekers BLT; Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands., Erdkamp FLG; Department of Medical Oncology, Zuyderland Medical Centre, Geleen, The Netherlands., Bouma JM; Department of Trial Registration, Comprehensive Cancer Centre the Netherlands, Rotterdam, The Netherlands., van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, The Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands., Bos MEMM; Department of Medical Oncology, Erasmus Medical Centre, Rotterdam, The Netherlands. |